CAD 0.07
(0.0%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 142.98 Million CAD | 1.5% |
2022 | 140.88 Million CAD | 11.87% |
2021 | 125.92 Million CAD | 41.92% |
2020 | 88.73 Million CAD | 0.21% |
2019 | 88.54 Million CAD | -17.51% |
2018 | 107.33 Million CAD | 9374048.47% |
2017 | 1145.00 CAD | 4.95% |
2016 | 1091.00 CAD | 23.42% |
2015 | 884.00 CAD | -99.37% |
2014 | 139.91 Thousand CAD | -86.0% |
2013 | 999.3 Thousand CAD | -38.36% |
2012 | 1.62 Million CAD | -47.63% |
2011 | 3.09 Million CAD | 42.97% |
2010 | 2.16 Million CAD | 11.87% |
2009 | 1.93 Million CAD | -78.93% |
2008 | 9.18 Million CAD | 5.59% |
2007 | 8.69 Million CAD | 69.22% |
2006 | 5.14 Million CAD | -6.16% |
2005 | 5.47 Million CAD | 609.49% |
2004 | 772.14 Thousand CAD | 39.53% |
2003 | 553.38 Thousand CAD | -12.82% |
2002 | 634.74 Thousand CAD | -8.76% |
2001 | 695.68 Thousand CAD | -6.11% |
2000 | 740.91 Thousand CAD | 53.89% |
1999 | 481.45 Thousand CAD | -14.58% |
1998 | 563.64 Thousand CAD | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q2 | 130.8 Million CAD | -4.6% |
2024 Q1 | 137.1 Million CAD | -4.11% |
2023 Q3 | 144.94 Million CAD | 6.05% |
2023 FY | 142.98 Million CAD | 1.5% |
2023 Q2 | 136.67 Million CAD | -3.7% |
2023 Q1 | 141.92 Million CAD | 0.74% |
2023 Q4 | 142.98 Million CAD | -1.35% |
2022 Q4 | 140.88 Million CAD | -1.33% |
2022 Q1 | 130.5 Million CAD | 3.63% |
2022 Q2 | 131.62 Million CAD | 0.85% |
2022 FY | 140.88 Million CAD | 11.87% |
2022 Q3 | 142.78 Million CAD | 8.48% |
2021 Q2 | 102.73 Million CAD | 7.68% |
2021 Q1 | 95.4 Million CAD | 7.51% |
2021 FY | 125.92 Million CAD | 41.92% |
2021 Q4 | 125.92 Million CAD | 4.59% |
2021 Q3 | 120.39 Million CAD | 17.2% |
2020 Q1 | 85.7 Million CAD | -3.2% |
2020 Q4 | 88.73 Million CAD | 5.51% |
2020 Q3 | 84.09 Million CAD | -1.59% |
2020 FY | 88.73 Million CAD | 0.21% |
2020 Q2 | 85.45 Million CAD | -0.3% |
2019 Q2 | 121.13 Million CAD | 15.3% |
2019 Q1 | 105.06 Million CAD | 0.0% |
2019 FY | 88.54 Million CAD | -17.51% |
2019 Q4 | 88.54 Million CAD | -29.06% |
2019 Q3 | 124.81 Million CAD | 3.04% |
2018 Q2 | 425.58 Thousand CAD | -9.43% |
2018 Q3 | 201.41 Thousand CAD | -52.67% |
2018 Q1 | 469.87 Thousand CAD | 13109.78% |
2018 FY | 107.33 Million CAD | 9374048.47% |
2017 Q2 | 1145.00 CAD | -15.93% |
2017 Q4 | 3557.00 CAD | 244.34% |
2017 FY | 1145.00 CAD | 4.95% |
2017 Q1 | 1362.00 CAD | -16.65% |
2017 Q3 | 1033.00 CAD | -9.78% |
2016 Q4 | 1634.00 CAD | -6.58% |
2016 FY | 1091.00 CAD | 23.42% |
2016 Q3 | 1749.00 CAD | 60.31% |
2016 Q2 | 1091.00 CAD | -19.66% |
2016 Q1 | 1358.00 CAD | 28.6% |
2015 Q3 | 1610.00 CAD | 82.13% |
2015 Q4 | 1056.00 CAD | -34.41% |
2015 Q2 | 884.00 CAD | -65.28% |
2015 Q1 | 2546.00 CAD | -92.11% |
2015 FY | 884.00 CAD | -99.37% |
2014 Q3 | 89.13 Thousand CAD | -36.29% |
2014 Q2 | 139.91 Thousand CAD | -60.73% |
2014 FY | 139.91 Thousand CAD | -86.0% |
2014 Q1 | 356.25 Thousand CAD | -39.73% |
2014 Q4 | 32.26 Thousand CAD | -63.8% |
2013 Q2 | 999.3 Thousand CAD | -17.26% |
2013 Q1 | 1.2 Million CAD | -36.54% |
2013 Q3 | 801.2 Thousand CAD | -19.82% |
2013 Q4 | 591.09 Thousand CAD | -26.22% |
2013 FY | 999.3 Thousand CAD | -38.36% |
2012 Q3 | 2.23 Million CAD | 37.97% |
2012 Q4 | 1.9 Million CAD | -14.92% |
2012 FY | 1.62 Million CAD | -47.63% |
2012 Q1 | 2.62 Million CAD | -18.76% |
2012 Q2 | 1.62 Million CAD | -38.17% |
2011 Q3 | 3.16 Million CAD | 2.23% |
2011 Q4 | 3.22 Million CAD | 1.98% |
2011 FY | 3.09 Million CAD | 42.97% |
2011 Q1 | 4.09 Million CAD | -23.45% |
2011 Q2 | 3.09 Million CAD | -24.35% |
2010 Q3 | 2.23 Million CAD | 3.06% |
2010 Q4 | 5.34 Million CAD | 139.54% |
2010 FY | 2.16 Million CAD | 11.87% |
2010 Q2 | 2.16 Million CAD | 45.92% |
2010 Q1 | 1.48 Million CAD | 72.87% |
2009 Q2 | 1.93 Million CAD | -1.26% |
2009 FY | 1.93 Million CAD | -78.93% |
2009 Q4 | 858.37 Thousand CAD | -60.53% |
2009 Q1 | 1.96 Million CAD | -77.83% |
2009 Q3 | 2.17 Million CAD | 12.37% |
2008 Q2 | 9.18 Million CAD | -1.58% |
2008 Q4 | 8.84 Million CAD | -0.69% |
2008 Q3 | 8.9 Million CAD | -3.07% |
2008 Q1 | 9.33 Million CAD | 11.59% |
2008 FY | 9.18 Million CAD | 5.59% |
2007 Q1 | 5.85 Million CAD | 10.38% |
2007 Q4 | 8.36 Million CAD | -2.05% |
2007 Q3 | 8.53 Million CAD | -1.84% |
2007 Q2 | 8.69 Million CAD | 48.5% |
2007 FY | 8.69 Million CAD | 69.22% |
2006 Q2 | 5.14 Million CAD | -11.09% |
2006 Q3 | 5.1 Million CAD | -0.74% |
2006 Q1 | 5.78 Million CAD | 7.52% |
2006 Q4 | 5.3 Million CAD | 4.01% |
2006 FY | 5.14 Million CAD | -6.16% |
2005 Q3 | 5.44 Million CAD | -0.69% |
2005 Q2 | 5.47 Million CAD | 1.78% |
2005 FY | 5.47 Million CAD | 609.49% |
2005 Q4 | 5.37 Million CAD | -1.16% |
2005 Q1 | 5.38 Million CAD | -1.89% |
2004 Q1 | 695.3 Thousand CAD | -2.3% |
2004 Q2 | 772.14 Thousand CAD | 11.05% |
2004 Q4 | 5.48 Million CAD | 145.16% |
2004 FY | 772.14 Thousand CAD | 39.53% |
2004 Q3 | 2.23 Million CAD | 189.82% |
2003 FY | 553.38 Thousand CAD | -12.82% |
2003 Q4 | 711.66 Thousand CAD | -3.34% |
2003 Q3 | 736.24 Thousand CAD | 33.04% |
2003 Q2 | 553.38 Thousand CAD | -4.48% |
2003 Q1 | 579.34 Thousand CAD | -3.1% |
2002 Q4 | 597.86 Thousand CAD | -4.92% |
2002 Q3 | 628.8 Thousand CAD | -0.94% |
2002 Q2 | 634.74 Thousand CAD | -1.07% |
2002 FY | 634.74 Thousand CAD | -8.76% |
2002 Q1 | 641.61 Thousand CAD | -2.47% |
2001 Q1 | 700.53 Thousand CAD | 0.0% |
2001 FY | 695.68 Thousand CAD | -6.11% |
2001 Q4 | 657.88 Thousand CAD | -4.32% |
2001 Q3 | 687.57 Thousand CAD | -1.16% |
2001 Q2 | 695.68 Thousand CAD | -0.69% |
2000 Q2 | 740.91 Thousand CAD | 0.0% |
2000 FY | 740.91 Thousand CAD | 53.89% |
2000 Q3 | 729.55 Thousand CAD | -1.53% |
1999 Q3 | 481.36 Thousand CAD | 0.0% |
1999 FY | 481.45 Thousand CAD | -14.58% |
1998 FY | 563.64 Thousand CAD | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
Aequus Pharmaceuticals Inc. | 1.08 Million CAD | -13063.687% |
CanadaBis Capital Inc. | 22.96 Million CAD | -522.683% |
Delivra Health Brands Inc. | 10.05 Million CAD | -1322.473% |
Entourage Health Corp. | 31.39 Million CAD | -355.478% |
Lifeist Wellness Inc. | 13.39 Million CAD | -967.136% |
Cannara Biotech Inc. | 141.52 Million CAD | -1.035% |
Medicure Inc. | 28.05 Million CAD | -409.594% |
PharmaCielo Ltd. | 22.28 Million CAD | -541.503% |
Rubicon Organics Inc. | 54.89 Million CAD | -160.492% |
BioSyent Inc. | 41.52 Million CAD | -244.307% |
Voyageur Pharmaceuticals Ltd. | 2.16 Million CAD | -6508.565% |